SELECTION :
- Protonitazene metabolite variability in postmortem casework. Wood R., Moore R., p. 427-435.
- North America laboratory survey data for drug testing in drug-impaired driving and traffic fatality investigations. D'Orazio A.L., Mohr A.L.A., Chan-Hosokawa A., Harper C., Huestis M.A., Kerrigan S., et al., p. 436-441.
- Evaluation of DrugWipe® 6S with the WipeAlyser® reader for drug screening of drivers. Jamt R.E.G., Gjerde H., Clausen G.B., Bache-Andreassen L., Oiestad E.L., p. 442-449.
- Oral fluid device performance in identifying amphetamine, methamphetamine, and cocaine use in Brazilian drivers. Dos Santos B.P., Scherer J.N., Viola P.P., Govoni B., Vasconcelos M., Dalanhol C.S., et al., p. 450-459.
- Synthetic cannabinoid receptor agonists in oral fluid: development of a dispersive liquid-liquid microextraction method with liquid chromatography-mass spectrometry detection. Bombana H.S., de Paula Meirelles G., de Oliveira R.A., Leyton V., Yonamine M., p. 460-468.
- Comparison of Δ9-tetrahydrocannabinol in venous and capillary blood following ad libitum cannabis smoking by occasional and daily users. Dooley G., Godbole S., Wrobel J., Henthorn T., Brooks-Russell A., Limbacher S., et al., p. 476-484.
- Preparation and stability characterization of flavour ingredients in E-liquids for preclinical assessment of electronic nicotine delivering system products: a case study of 38 flavour ingredients in a single mixture. Miller J.H.t., Hurst T.J., Shah N.H., Zhang J., Frauendorfer F., Guy P., et al., p. 496-504.